VITALE, ANTONIO
 Distribuzione geografica
Continente #
NA - Nord America 7.255
EU - Europa 6.339
AS - Asia 827
SA - Sud America 11
AF - Africa 10
OC - Oceania 10
Continente sconosciuto - Info sul continente non disponibili 5
Totale 14.457
Nazione #
US - Stati Uniti d'America 7.246
GB - Regno Unito 2.558
IE - Irlanda 982
IT - Italia 881
CN - Cina 635
UA - Ucraina 578
SE - Svezia 524
FR - Francia 266
DE - Germania 244
FI - Finlandia 168
VN - Vietnam 74
TR - Turchia 33
BE - Belgio 27
RU - Federazione Russa 23
CZ - Repubblica Ceca 21
PL - Polonia 21
IN - India 19
PK - Pakistan 18
NL - Olanda 14
ES - Italia 11
AU - Australia 9
JP - Giappone 9
IR - Iran 8
BR - Brasile 7
CA - Canada 7
HK - Hong Kong 6
EU - Europa 5
MA - Marocco 5
GR - Grecia 4
PT - Portogallo 4
SA - Arabia Saudita 4
BD - Bangladesh 3
EG - Egitto 3
AL - Albania 2
HU - Ungheria 2
IL - Israele 2
KE - Kenya 2
KR - Corea 2
KZ - Kazakistan 2
LT - Lituania 2
MY - Malesia 2
PA - Panama 2
PE - Perù 2
SG - Singapore 2
AM - Armenia 1
AT - Austria 1
AZ - Azerbaigian 1
BG - Bulgaria 1
BY - Bielorussia 1
CL - Cile 1
CY - Cipro 1
DK - Danimarca 1
EC - Ecuador 1
ID - Indonesia 1
IQ - Iraq 1
KG - Kirghizistan 1
LA - Repubblica Popolare Democratica del Laos 1
LV - Lettonia 1
NZ - Nuova Zelanda 1
RO - Romania 1
SK - Slovacchia (Repubblica Slovacca) 1
TM - Turkmenistan 1
Totale 14.457
Città #
Southend 2.456
Fairfield 1.212
Dublin 968
Ashburn 644
Woodbridge 565
Jacksonville 473
Wilmington 468
Chandler 463
Seattle 461
Houston 445
Cambridge 420
Ann Arbor 326
Menlo Park 319
Siena 295
Princeton 233
Nanjing 151
Beijing 133
New York 131
Helsinki 88
San Mateo 86
Dong Ket 73
Dearborn 72
San Diego 72
Boardman 64
Nanchang 58
Milan 52
Shenyang 41
Düsseldorf 35
Rome 33
Shanghai 28
Tianjin 28
Jiaxing 27
Izmir 26
Hebei 25
Changsha 24
Brussels 23
Washington 23
Norwalk 21
Kraków 20
Olomouc 18
Bologna 17
Jinan 17
Kunming 17
Florence 15
San Francisco 14
Guangzhou 13
London 13
Redwood City 13
Los Angeles 11
Saint Petersburg 11
Frankfurt am Main 10
Málaga 10
Tappahannock 10
Turin 10
Cecina 9
Lancaster 9
Monza 9
Padova 9
Sutri 9
Changchun 8
Hangzhou 8
Lahore 8
Lanzhou 8
Taizhou 8
Zhengzhou 8
Cagliari 7
Falls Church 7
Palermo 7
Perugia 7
Venezia 7
Asciano 6
Campi Bisenzio 6
Catania 6
Brindisi 5
Fremont 5
Ningbo 5
Paris 5
Ravenna 5
Seveso 5
Uzzano 5
Venice 5
Zanjan 5
Budrio 4
Cardiff 4
Casoria 4
Edinburgh 4
Islamabad 4
Jhelum 4
Lisbon 4
Livorno 4
Phoenix 4
Salerno 4
Toronto 4
Trento 4
Amsterdam 3
Augusta 3
Bari 3
Biella 3
Chicago 3
Codognè 3
Totale 11.538
Nome #
VEXAS syndrome: a new paradigm for adult-onset monogenic autoinflammatory diseases 330
Cumulative retention rate of adalimumab in patients with Behçet's disease-related uveitis: A four-year follow-up study 248
Ten-Year Retention Rate of Infliximab in Patients with Behçet’s Disease-Related Uveitis 238
Long-term retention rates of adalimumab and infliximab in non-infectious intermediate, posterior, and panuveitis 223
Comparative efficacy between adalimumab and infliximab in the treatment of non-infectious intermediate uveitis, posterior uveitis, and panuveitis: a retrospective observational study of 107 patients 200
Efficacy of adalimumab and infliximab in recalcitrant retinal vasculitis inadequately responsive to other immunomodulatory therapies 192
Weekly oral alendronate in mevalonate kinase deficiency 187
Auditory involvement in Behcet’s disease: relationship with demographic, clinical, and therapeutic characteristics 187
A Snapshot on the On-Label and Off-Label Use of the Interleukin-1 Inhibitors in Italy among Rheumatologists and Pediatric Rheumatologists: A Nationwide Multi-Center Retrospective Observational Study 181
Rapid and Sustained Efficacy of Golimumab in the Treatment of Multirefractory Uveitis Associated with Behçet’s Disease 180
A comprehensive comparison between pediatric and adult patients with periodic fever, aphthous stomatitis, pharyngitis, and cervical adenopathy (PFAPA) syndrome 176
The Presence of Uveitis Is Associated with a Sustained Response to the Interleukin (IL)-1 Inhibitors Anakinra and Canakinumab in Behçet's Disease 176
The diagnostic evaluation of patients with a suspected hereditary periodic fever syndrome: experience from a referral center in Italy 171
Quality of life impairment in Behçet’s disease and relationship with disease activity: a prospective study 167
Predictors of sustained clinical response in patients with Behçet’s disease-related uveitis treated with infliximab and adalimumab 166
Biological treatments: new weapons in the management of monogenic autoinflammatory disorders 165
Working the endless puzzle of hereditary autoinflammatory disorders. 164
Safety profile of the interleukin-1 inhibitors anakinra and canakinumab in real-life clinical practice: a nationwide multicenter retrospective observational study 164
Caveats and truths in genetic, clinical, autoimmune and autoinflammatory issues in Blau syndrome and early onset sarcoidosis 163
Systemic Steroid Sparing Effect of Intravitreal Dexamethasone Implant in Chronic Noninfectious Uveitic Macular Edema 163
Certolizumab Pegol treatment in Behcet’s disease with different organ involvement: a multicenter retrospective observational study 158
Efficacy and safety of anakinra in tumor necrosis factor receptor-associated periodic syndrome (TRAPS) complicated by severe renal failure: a report after long-term follow-up and review of the literature 157
Long-term efficacy and safety of golimumab in the treatment of multirefractory Behçet’s disease 154
Switch from infliximab to infliximab biosimilar: efficacy and safety in a cohort of patients with different rheumatic diseases: Response to: Nikiphorou E, Kautiainen H, Hannonen P, et al. Clinical effectiveness of CT-P13 (Infliximab biosimilar) used as a switch from Remicade (infliximab) in patients with established rheumatic disease. Report of clinical experience based on prospective observational data. Expert Opin Biol Ther. 2015;15:1677–1683 152
Adalimumab effectiveness in Behçet’s disease: short and long-term data from a multicenter retrospective observational study 152
Challenges and new horizons in the periodic fever, aphthous stomatitis, pharyngitis and adenitis (PFAPA) syndrome 151
null 150
Efficacy and Safety of Adalimumab in Behçet’s disease related uveitis: a multicenter retrospective observational study 150
Impact of Uveitis on Quality of Life: A Prospective Study from a Tertiary Referral Rheumatology-Ophthalmology Collaborative Uveitis Center in Italy 148
Immunometabolic biomarkers of inflammation in Behçet's disease: Relationship with epidemiological profile, disease activity and therapeutic regimes 145
The hereditary autoinflammatory disorders uncovered 143
Correlation between serum amyloid-A and serum levels of proinflammatory cytokines in patients with Behçet's disease 143
Coexistence of axial spondyloarthritis and thromboangiitis obliterans in a young woman 137
Diagnostic criteria for adult-onset periodic fever, aphthous stomatitis, pharyngitis, and cervical adenitis (PFAPA) syndrome 137
The diagnostic evaluation of patients with potential adult-onset autoinflammatory disorders: our experience and review of the literature 137
Interleukin (IL)-1 inhibition with anakinra and canakinumab in Behçet’s disease-related uveitis: a multicenter retrospective observational study 136
The common NOD2/CARD15 variant P268S in patients with non-infectious uveitis: a cohort study 135
Clinical and biochemical landmarks in systemic autoinflammatory diseases 134
Interleukin-1 as a common denominator from autoinflammatory to autoimmune disorders: premises, perils, and perspectives 133
Childhood versus adulthood-onset autoinflammatory disorders: myths and truths intertwined 131
null 131
Correlation of Serum Amyloid-A Levels, Clinical Manifestations, Treatment, and Disease Activity in Patients with Behçet's Disease 130
Critical regulation of Th17 cell differentiation by serum amyloid-A signalling in Behcet's disease 129
Relapsing Polychondritis: an Update on Pathogenesis, Clinical Features, Diagnostic Tools, and Therapeutic Perspectives 128
The eye involvement in monogenic autoinflammatory diseases: Literature review and update 127
Treating juvenile idiopathic arthritis (JIA)-related uveitis beyond TNF-α inhibition: a narrative review 127
Idiopathic inflammatory myopathies: an update on classification and treatment with special focus on juvenile forms 126
The role of the F402L allele in the NLRP12-autoinflammatory disorder. Reply to: F402L variant in NLRP12 in subjects with undiagnosed periodic fevers and in healthy controls, De Pieri et al 126
Long-term efficacy and safety of the interleukin-1 inhibitors anakinra and canakinumab in refractory Behçet disease uveitis and concomitant bladder papillary carcinoma 125
Mucocutaneous Involvement in Behçet's Disease: How Systemic Treatment Has Changed in the Last Decades and Future Perspectives 125
Behçet’s syndrome in Italy: a detailed retrospective analysis of 396 cases seen in 3 tertiary referral clinics 125
Adalimumab effectively controls both anterior and posterior noninfectious uveitis associated with systemic inflammatory diseases: focus on Behçet’s syndrome 125
The expanding spectrum of low-penetrance TNFRSF1A gene variants in adults presenting with recurrent inflammatory attacks: Clinical manifestations and long-term follow-up 124
Diagnosis and classification of relapsing polychondritis 123
Long-term efficacy and safety of anakinra in a patient with Behçet's disease and concomitant tuberculosis infection 123
Monogenic autoinflammatory syndromes: state of the art on genetic, clinical, and therapeutic issues 122
Serum amyloid-A in Behçet's disease 122
Adalimumab-Based Treatment Versus Disease-Modifying Antirheumatic Drugs for Venous Thrombosis in Behçet's Syndrome: A Retrospective Study of Seventy Patients With Vascular Involvement 122
null 121
Key facts and hot spots on tumor necrosis factor receptor-associated periodic syndrome 121
null 119
A case of resistant adult-onset periodic fever, aphthous stomatitis, pharyngitis and cervical adenitis (PFAPA) syndrome responsive to anakinra. 118
null 118
null 117
null 116
Circulating intercellular adhesion molecule 1 (sICAM-1) in tumour necrosis factor receptor-associated periodic syndrome (TRAPS) 116
null 115
null 115
Long-term safety of anti-TNF agents on the liver of patients with spondyloarthritis and potential occult hepatitis B viral infection: An observational multicentre study 115
Prompt Clinical Response to Secukinumab in Patients with Axial Spondyloarthritis: Real Life Observational Data from Three Italian Referral Centers 115
Inhibition of Interleukin-1 by Canakinumab as a Successful Mono-Drug Strategy for the Treatment of Refractory Behçet's Disease: A Case Series 114
null 113
Paradoxical mucocutaneous flare in a case of Behçet's disease treated with tocilizumab 113
null 112
Anakinra long-term efficacy and safety in the management of Schnitzler's syndrome and latent tuberculosis infection 112
Clues to detect tumor necrosis factor receptor-associated periodic syndrome (TRAPS) among patients with idiopathic recurrent acute pericarditis: results of a multicentre study 112
Role of Colchicine Treatment in Tumor Necrosis Factor Receptor Associated Periodic Syndrome (TRAPS): Real-Life Data from the AIDA Network 109
null 107
null 107
null 104
null 102
Proinflammatory Cytokines and Antiskin Autoantibodies in Patients With Inherited Epidermolysis Bullosa 102
Evolving Frontiers in the Treatment of Periodic Fever, Aphthous Stomatitis, Pharyngitis, Cervical Adenitis (PFAPA) Syndrome 102
Long-Term Outcomes of Behçet's Syndrome-Related Uveitis: A Monocentric Italian Experience 102
null 98
null 95
null 94
Rare NLRP12 variants associated with the NLRP12-autoinflammatory disorder phenotype: an Italian case series 93
The most recent advances in pathophysiology and management of tumour necrosis factor receptor-associated periodic syndrome (TRAPS): personal experience and literature review 92
Diagnosis of PFAPA syndrome applied to a cohort of 17 adults with unexplained recurrent fevers 92
Interleukin-1: Ariadne's Thread in Autoinflammatory and Autoimmune Disorders 88
Successful use of canakinumab in a patient with resistant Behçet's disease 86
Comparison of Early vs. Delayed Anakinra Treatment in Patients With Adult Onset Still's Disease and Effect on Clinical and Laboratory Outcomes 84
Adalimumab Accounts for Long-Term Control of Noninfectious Uveitis Also in the Absence of Concomitant DMARD Treatment: A Multicenter Retrospective Study 84
Expanding spectrum of TNFRSF1A gene mutations among patients with idiopathic recurrent acute pericarditis 82
Long-term clinical course of patients carrying the Q703K mutation in the NLRP3 gene: a case series 81
Efficacy of anakinra in refractory Behçet's disease sacroiliitis 81
Hints for Genetic and Clinical Differentiation of Adult-Onset Monogenic Autoinflammatory Diseases 80
Leptin, adiponectin, resistin, visfatin serum levels and idiopathic recurrent pericarditis: biomarkers of disease activity? A preliminary report 78
null 76
Totale 13.285
Categoria #
all - tutte 39.065
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 39.065


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019410 0 0 0 0 0 0 0 0 0 0 0 410
2019/20203.092 354 142 174 431 166 276 260 373 310 317 103 186
2020/20212.673 251 260 108 220 190 353 105 396 119 262 154 255
2021/20221.917 183 234 118 134 99 35 82 64 142 231 205 390
2022/20231.801 116 151 244 220 168 341 54 140 209 24 78 56
2023/20241.846 78 47 173 109 96 517 550 81 17 68 65 45
Totale 14.850